Publications

Search our bibliography using the filters on the right-hand side.

Displaying 51 through 93 of 93 publications.

Arana A, Wentworth CE, Rivero E, Plana E, Conde E. Lymphoma among patients with atopic dermatitis treated with topical corticosteroids (TCS) and/or topical calcineurin inhibitors (TCIs). Poster presented at the 26th International Conference on Pharmacoepidemiology; August 2010. Brighton, England. [abstract] Pharmacoepidemiol Drug Saf. 2010 Aug; 19(S1):S12.

Martín-Merino M, Fortuny J, Plana E, Rivero E, García-Rodríguez LA. Incidence of diabetic retinopathy and diabetic macular edema in newly diagnosed type I and type 2 diabetic patients. Poster presented at the 26th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2010. Brighton, United Kingdom. [abstract] Pharmacoepidemiol Drug Saf. 2010 Aug; 19(Suppl 1):S251-2.

López-León S, Fortuny J, Plana E, Rivero E. The pattern of use of anti-depressant drugs. Poster presented at the 26th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2010. Brighton, United Kingdom. [abstract] Pharmacoepidemiol Drug Saf. 2010 Aug; 19(1):S289.

Loughlin J, Quinn S, Rivero E, Wong J, Huang J, Kralstein J. Tegaserod and the risk of cardiovascular ischemic events: an observational cohort study. J Cardiovasc Pharmacol. 2010 Jun;15(2):151-7.

Loughlin J, Quinn S, Rivero E, Norman H, Earnest DL, Wong J, Seeger JD. No evidence for association of tegaserod with suicide-related outcomes. Poster presented at the 25th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2009. Providence, RI. [abstract] Pharmacoepidemiol Drug Saf. 2009 Aug; 18(Suppl 1):S154-5.

Loughlin J, Quinn S, Rivero E, Norman H, Earnes DL, Wong J, Seeger JD. No evidence for association of tegaserod with adverse cardiovascular ischemic events. Presented at the 25th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2009. Providence, RI. [abstract] Pharmacoepidemiol Drug Saf. 2009 Aug; 18(Suppl 1):S17.

Arana A, Arellano FM, Rivero E, Wentworth CW, Fortuny J. Incidence of endophthalmitis after intravitreal injection procedures in the general population of the United States of America. Poster presented at the 25th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2009. Providence, RI. [abstract] Pharmacoepidemiol Drug Saf. 2009 Aug; 18(Suppl 1):S151-2.

Seeger JD, Loughlin J, Rivero E, Earnest DL, Quinn SG, Huang J, Rueegg P, Dennis E, Kralstein J. No evidence for association of tegaserod with cardiovascular adverse ischemic events (CVIE) in routine clinical practice. Presented at the Annual Meeting of the American College of Gastroenterology; October 2008. Orlando, FL.

Arellano FM, Yood MU, Wentworth CE, Oliveria SA, Rivero E, Arana A, Rothman KJ. Use of Cyclo-Oxygenase 2 Inhibitors (COX-2) and prescription Non-Steroidal Anti-Inflammatory Drugs (NSAIDS) in UK and USA populations. Pharmacoepidemiol Drug Saf. 2008 Oct 1;17(10):1037. doi: 10.1002/pds.1636

Arana A, Arellano FM, Rivero E, Pavesi M, Dey D, Wentworth CW. Intravitreal (IVT) injection-related ocular adverse events in the general population of the United States of America. Poster presented at the 24th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2008. Copenhagen, Denmark. [abstract] Pharmacoepidemiol Drug Saf. 2008 Aug; 17(Suppl 1):S75-6.

Wentworth CW, Arellano FM, Rivero E, Pavesi M, Dey D, Arana A. Use of intravitreal (IVT) injection therapies in the general population of the United States of America. Presented at the 24th International Conference on Pharmacoepidemiology; August 2008. Copenhagen, Denmark. [abstract] Pharmacoepidemiol Drug Saf. 2008 Aug; 17(Suppl 1):S251-2.

Huerta C, Rivero E, Rodriguez LA. Incidence and risk factors for psoriasis in the general population. Arch Dermatol. 2007 Dec;143(12):1559-65.

Seeger JD, Schneeweiss S, Doherty M, Dey D, Rivero E. Pattern of Visudyne® use among patients enrolled in a US health insurance database. Poster presented at the 23rd International Conference on Pharmacoepidemiology and Therapeutic Risk Management; August 2007. Quebec City, Canada. [abstract] Pharmacoepidemiol Drug Saf. 2007 Aug 20; 16(Suppl 2):S105.

Seeger JD, West WA, Fernandez C, Rivero E. Pregnancy and pregnancy outcome among women with inflammatory skin diseases. Dermatology. 2006 Dec 1;214(1):32-9.

Arellano FM, Yood MU, Wentworth CE, Oliveria SA, Rivero E, Verma A, Rothman KJ. Use of Cyclo-Oxygenase 2 Inhibitors (COX-2) and prescription Non-Steroidal Anti-Inflammatory Drugs (NSAIDS) in UK and USA populations. Implications for COX-2 cardiovascular profile. Pharmacoepidemiol Drug Saf. 2006 Dec 1;15(12):861-72.

Gonzalez-Perez A, Fernandez-Vidaurre C, Rueda A, Rivero E, Garcia-Rodriguez LA. Cancer incidence in a general population of asthma patients. Pharmacoepidemiol Drug Saf. 2006 Nov 15;15(2):131-8.

Seeger JD, Ziyadeh N, Lievano F, Rivero E, Earnest DL, Shetzline M, Holden W, Walker AM. Nested case-control validation of results of the Zelnorm™ epidemiological study. Presented at the 22nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2006. Lisbon, Portugal. [abstract] Pharmacoepidemiol Drug Saf. 2006 Aug; 15(Suppl 1):S32.

Seeger JD, Quinn S, Lievano F, Rivero E, Earnest DL, Shetzline M, Holden W, Walker AM. No increased risk of abdominal or pelvic surgery associated with tegaserod exposure: the zelnormTM epidemiological study. Presented at the 22nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management,; August 2006. Lisbon, Portugal. [abstract] Pharmacoepidemiol Drug Saf. 2006 Aug; 15(Suppl 1):S12-3.

Huerta C, Rivero E, Gil M, Garcia-Rodriguez LA. Incidence and natural history of psoriasis diagnosed in general practice. Poster presented at the 22nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2006. Lisbon, Portugal. [abstract] Pharmacoepidemiol Drug Saf. 2006 Aug; 15(Suppl 1):S275-6.

Huerta C, Montoro MA, Sanchez B, Rivero E, Lievano F, Garcia-Rodriguez LA. Incidence and risk factors for intestinal ischemia. Poster presented at the 22nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2006. Lisbon, Portugal. [abstract] Pharmacoepidemiol Drug Saf. 2006 Aug; 15(Suppl 1):S268.

Arellano FA, Wentworth CE, May C, Verma A, Rivero E, Rothman KJ. Use of prescription Cyclo-Oxygenase 2 Inhibitors (COX-2) and non COX-2 Non-Steroidal Anti-Inflammatory Drugs (NSAID) in a UK population. Poster presented at the 21st ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; June 2005. Nashville, TN. [abstract] Pharmacoepidemiol Drug Saf. 2005 Sep; 14(Suppl S2):S141. doi: 10.1002/pds.1136

Arellano FA, Wentworth CE, May C, Verma A, Rivero E, Rothman KJ. Use of prescription cyclo-oxigenase 2 inhibitors (COX-2) and non cox-2 non-steroidal anti-inflammatory drugs (NSAIDS) in a UK population. Pharmacoepidemiol Drug Saf. 2005 Jul;14(Suppl 1):S141.

Arana A, Rivero E, Egberts TCG. What do we show and who does so? An analysis of the abstracts presented at the 19th ICPE. Presented at the 20th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 22, 2004. Bordeaux, France. [abstract] Pharmacoepidemiol Drug Saf. 2004 Sep 23; 13(Suppl 1):s330-1.

Lanza L, Rivero Ferrer M, Fernández C, West WA, Seeger JD. Pregnancy incidence among women with inflammatory skin disorders. Poster presented at the 20th International Conference on Pharmacoepidemiology; August 2004. Bordeaux, France. [abstract] Pharmacoepidemiol Drug Saf. 2004 Aug; 13(Suppl 1):S206-7.

Rivero E, Huerta C, Garcia-Rodriguez LA, Fernandez-Vidaurre C, Abrams BB. The risk of lymphoid neoplasms and other hematological malignancies in patients with atopic dermatitis. Poster presented at the 19th International Conference on Pharmacoepidemiology; August 2003. Philadelphia, PA. [abstract] Pharmacoepidemiol Drug Saf. 2003 Aug; 12(Suppl 1):S110-1.

Rivero E, Alexander M, Iribarren C, Ordoñez J, Shandling M, Go AS. Lipid monitoring and lipid profiles in kidney transplant patients within a large health maintenance organization: 1995-1999. Poster presented at the American Transplant Congress; May 2003. Washington, DC.

Rivero E, Varas-Lorenzo C, Rueda de Castro A, Blanch C, Maguire A. Long-term prediction of coronary heart disease risk in a renal transplant clinical trial. Poster presented at the 18th ICPE International Conference on Pharmacoepidemiology; August 21, 2002. Edinburgh, Scotland. [abstract] Pharmacoepidemiol Drug Saf. 2002 Aug 21; 11(Suppl 1):S152.

Noronha IL, Eisen HJ, Pedersen PR, Rivero E. Long-term predicted probability of coronary heart disease in renal transplant recipients treated with everolimus or MMF: an estimation based on the first year of treatment by applying a Framingham prediction model. Poster presented at the XIX International Congress of the Transplantation Society; August 2002. Miami, FL.

Rivero E, Varas-Lorenzo C, Maguire AR, Eisen HJ, Pedersen TR, Nashan B, Elkammas E. 10-Year predicted probability of coronary heart disease in renal transplant recipients treated with everolimus or mmf. Poster presented at the American Transplant Congress; April 2002. Washington, DC. [abstract] Am J Transplant. 2002; 2(Suppl 3):418.

Duh MS, Rivero E, Varas-Lorenzo C, Funch D, Velentgas P, Walker AM. Lipid data collection practices in U.S. renal transplant centers. Poster presented at the 17th International Conference on Pharmacoepidemiology; August 26, 2001. Toronto, Canada. [abstract] Pharmacoepidemiol Drug Saf. 2001 Aug 26; (Suppl 1):S23.

Calvet X, Navarro M, Gil M, Lafont A, Sanfeliu I, Brullet E, Campo R, Dalmau B, Rivero E, Mas P. Epidemiology of peptic ulcer disease in cirrhotic patients: role of helicobacter pylori infection. Am J Gastroenterol. 1998 Dec;93(12):2501-7.

López MV, Rivero E, Serra C, Campo M, Raurich M, Bonfill X. Health survey in health care professionals in Barcelona. Arch Prev Riesgos Laborales. 1998;1(2):55-62.

Calvet X, Navarro M, Gil M, Mas P, Rivero E, Sanfeliu I. Seroprevalence and epidemiology of Helicobacter pylori infection in patients with cirrhosis. J Hepatol. 1997 Jun;26(6):1249-54.

Bonfill X, Roura P, Moreno C, Rivero E, Rué M. Cancer mortality in the counties of Catalonia, Spain (1983-1989). Gac Sanit. 1997 Feb;11(2):74-82.

Brullet E, Campo R, Calvet X, Coroleu D, Rivero E, Simó Deu J. Factors related to the failure of endoscopic injection therapy for bleeding gastric ulcer. Gut. 1996 Aug;39(2):155-8. doi: 10.1136/gut.39.2.155

Bonfill X, Marzo M, Sentís M, Rossell M, Gallardo X, Rivero E. Evaluation of the regular practice of breast cancer screening in a health area. Int J Technol Assess Health Care. 1996 Apr;12(2):388-94.

Bonfill X, Moreno C, Prada G, Rivero E, Rué M. Lung cancer mortality among males of Catalonia and Spain compared with other European countries between 1975-1977 and 1987-1989. Int J Cancer. 1996 Mar 15;65(6):751-4.

Bonfill X, Rivero E, Moreno C, Rué M. Changes in cancer mortality in Catalonia and Spain (1975-77 and 1987-89). A comparison with other European countries. Eur J Cancer Prev. 1995 Dec;4(6):453-8.

Campo R, Brullet E, Montserrat A, Calvet X, Rivero E, Brotons C. Topical pharyngeal anesthesia improves tolerance of upper gastrointestinal endoscopy: a randomized double-blind study. Endoscopy. 1995 Nov;27(9):659-64.

Brotons C, Rivero E, Perich RM. Hypercholesterolemia in childhood and adolescence. Fmc - Formacion Medica. 1994;4:231-7.

Rivero E, Carrillo E, Portella E, Hernández I, Colom D. Evaluation of the design and reliability of a questionnaire to identify elderly individuals in need for social and health services. Med Clin (Barc). 1993 Dec;101(18):688-92.

Brotons C, Rué M, Rivero E, Pérez G. Tendencies of mortality from cardiovascular diseases in Catalonia: 1975-1992. Med Clin (Barc). 1993 Nov 13;101(16):604-8.

Portella E, Rivero E, Carrillo E, Colom D, Murillo C, Murillo J. Influence of municipal registry errors on the identification of a sample. Gac Sanit. 1991;5(25):183-4.